Spironolactone use and risk of incident cancers: a retrospective, matched cohort study

Aims Spironolactone is widely used to treat heart failure, hypertension and liver disease with increased usage in recent years. Spironolactone has endocrine effects that could influence cancer risks and historical reports suggest possible links with increased risk of certain types of cancer. The aim...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	British journal of clinical pharmacology Ročník 83; číslo 3; s. 653 - 663
Hlavní autori:	Mackenzie, Isla S., Morant, Steven V., Wei, Li, Thompson, Alastair M., MacDonald, Thomas M.
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	England John Wiley and Sons Inc 01.03.2017
Predmet:	Adult Aged Aged, 80 and over cancer Case-Control Studies cohort study Female Humans Incidence Male Middle Aged Neoplasms - chemically induced Neoplasms - epidemiology Pharmacoepidemiology Proportional Hazards Models prostate Retrospective Studies Risk Factors spironolactone Spironolactone - adverse effects United Kingdom - epidemiology Young Adult cancer prostate cohort study spironolactone pharmacoepidemiology
ISSN:	0306-5251, 1365-2125, 1365-2125
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!